Literature DB >> 29406970

Adjuvant intra-arterial rt-PA injection at the initially deployed solitaire stent enhances the efficacy of mechanical thrombectomy in acute ischemic stroke.

Ting-Yu Yi1, Wen-Huo Chen2, Yan-Min Wu1, Mei-Fang Zhang1, Ding-Lai Lin1, Xiao-Hui Lin1.   

Abstract

BACKGROUND: Both intra-arterial recombinant tissue plasminogen activator (rt-PA) and stent retrieval are effective for treating acute ischemic stroke. The goal of this study was to evaluate the effectiveness of stent retrieval combined with intra-arterial rt-PA administration via micro-catheter (called the complex technique) in acute ischemic stroke.
MATERIAL AND METHODS: A retrospective analysis was performed of 93 consecutive patients treated between 2015 and 2017 for occlusions of the intracranial large artery using the complex technique (n=37) or stent retrieval alone (n=56) in our stroke center. Data on procedure duration, number of passes, and angiographic findings were collected. Successful recanalization was defined as the accomplishment of grade 3 or 2b modified Treatment in Cerebral Ischemia recanalization in 1 or 2 passes.
RESULTS: Compared to the stent retrieval group, complex technique group had a higher successful revascularization rate with 1 or 2 passes with the stent retriever (81.1% versus 51.8%, P=0.004), a shorter procedure time (59±34min versus 94±56min, P<0.001), fewer passes of the stent retriever (1.8±1.1 versus 2.5±1.4, P=0.012), a better prognosis (70.3% versus 48.2%, P=0.035), a lower embolic complication rate (18.9% versus 39.3%, P=0.038), similar mortality (13.5% versus 21.4%, P=0.334) and similar intracranial hemorrhage symptoms (2.7% versus 12.5%, P=0.204). Intra-arterial rt-PA administration was an independent negative predictor of procedure time (OR=-0.292, P=0.003).
CONCLUSION: Mechanical thrombectomy utilizing stent retrieval combined with intra-arterial rt-PA administration in the anterior circulation of acute ischemic stroke patients improved the angiographic results and shortened the procedure duration without increasing adverse events.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; Embolic event; Intra-arterial thrombolysis; Mechanical thrombectomy

Mesh:

Substances:

Year:  2018        PMID: 29406970     DOI: 10.1016/j.jns.2018.01.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful, or Incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke.

Authors:  Johannes Kaesmacher; Sebastian Bellwald; Tomas Dobrocky; Thomas R Meinel; Eike I Piechowiak; Martina Goeldlin; Christoph C Kurmann; Mirjam R Heldner; Simon Jung; Pasquale Mordasini; Marcel Arnold; Pascal J Mosimann; Gerhard Schroth; Heinrich P Mattle; Jan Gralla; Urs Fischer
Journal:  JAMA Neurol       Date:  2020-03-01       Impact factor: 18.302

Review 2.  Intravenous thrombolysis before mechanical thrombectomy for acute ischemic stroke due to large vessel occlusion; should we cross that bridge? A systematic review and meta-analysis of 36,123 patients.

Authors:  Hazem S Ghaith; Mohamed Elfil; Mohamed Diaa Gabra; Asmaa Ahmed Nawar; Mohamed Sameh Abd-Alkhaleq; Khaled M Hamam; Lara Ebrahim Aboelnasr; Esraa Ayman Elgezery; Mohamed Hosny Osman; Hanaa Elsayed; Sarya Swed; Ulrick Sidney Kanmounye; Ahmed Negida
Journal:  Neurol Sci       Date:  2022-07-23       Impact factor: 3.830

3.  Clinical observation of thrombolytic effect of alteplase combined with butylphthalide in patients with acute anterior circulation cerebral infarction.

Authors:  Fan-Xing Qi; Ying Hu; Sen Wang
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

4.  Insights Into Intra-arterial Thrombolysis in the Modern Era of Mechanical Thrombectomy.

Authors:  Alicia C Castonguay; Mouhammad A Jumaa; Osama O Zaidat; Diogo C Haussen; Ashutosh Jadhav; Hisham Salahuddin; Syed F Zaidi
Journal:  Front Neurol       Date:  2019-11-13       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.